Fact CheckerSign in

NCT06926049Active, not recruiting

The Mindfulness-Based Psycho-Educational Program Focused on Emotion Regulation Strategies

The Effect of The Mindfulness-Based Psycho-Educational Program Focused on Emotions on Difficulties in Emotion Regulation, Depressive Symptoms and Hope Level in Schizophrenia Patients

Source: ClinicalTrials.gov · Last updated 20 Apr 2025

Brief summary (registry, in English)

In this study, the effects of a mindfulness-based emotion-focused psychoeducation program applied to individuals diagnosed with schizophrenia on emotion regulation difficulties, depressive symptoms, and hope levels will be examined. The research will be carried out as a randomized controlled experimental study with a pre-test-post-test and follow-up design.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
48 (estimated)
First submitted
7 Apr 2025
Start date
1 Mar 2025
Primary completion date
1 Oct 2025
Lead sponsor
Gazi University
NCT number
NCT06926049

What you commit to

  • Study type: Interventional
  • Planned participants: 48
  • From 1 Mar 2025 to the primary completion date, 1 Oct 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Having participated in and currently receiving a structured psychotherapeutic intervention program within the last year

Other illness

  • Having a neurological disease
  • Having a neurocognitive disease

Other

  • Having comorbid depression according to DSM-5 diagnostic criteria
  • Being a substance abuser

Who the study is looking for

  • Being diagnosed with schizophrenia according to DSM-5 diagnostic criteria
  • Being between 18-65 years old
  • Not having any problems with communication
  • Being literate
  • Being willing to participate in the research
  • Having schizophrenia for at least 2 years

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Gazi University
Coordinator of this site? Confirm its status
AnkaraTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.